How do business model and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs P Lehoux, G Daudelin, B Williams-Jones, JL Denis, C Longo Research Policy 43 (6), 1025-1038, 2014 | 196 | 2014 |
Actor-network theory: a tool to support ethical analysis of commercial genetic testing B Williams-Jones, JE Graham New genetics and society 22 (3), 271-296, 2003 | 196 | 2003 |
History of a gene patent: tracing the development and application of commercial BRCA testing B Williams-Jones Health Law Journal 10, 121-144, 2002 | 180 | 2002 |
Shifting emphasis from pharmacogenomics to theragnostics V Ozdemir, B Williams-Jones, SJ Glatt, MT Tsuang, JB Lohr, C Reist Nature Biotechnology 24 (8), 942-946, 2006 | 156 | 2006 |
Mapping the integration of social and ethical issues in health technology assessment P Lehoux, B Williams-Jones International Journal of Technology Assessment in Health Care 23 (1), 9-16, 2007 | 152 | 2007 |
Authorship and responsibility in health sciences research: a review of procedures for fairly allocating authorship in multi-author studies E Smith, B Williams-Jones Science and Engineering Ethics 18 (2), 199-212, 2012 | 128 | 2012 |
Where there’s a web, there’s a way: commercial genetic testing and the internet B Williams-Jones Public Health Genomics 6 (1), 46-57, 2003 | 97 | 2003 |
What leads to better health care innovation? Arguments for an integrated policy-oriented research agenda P Lehoux, B Williams-Jones, F Miller, D Urbach, S Tailliez Journal of health services research & policy 13 (4), 251-254, 2008 | 90 | 2008 |
Reproductive tourism in Argentina: clinic accreditation and its implications for consumers, health professionals and policy makers E Smith, J Behrmann, C Martin, B Williams-Jones Developing World Bioethics 10 (2), 59-69, 2010 | 77 | 2010 |
Rhetoric and Hype: Where's the 'Ethics' in Pharmacogenomics? B Williams-Jones, OP Corrigan American Journal of Pharmacogenomics 3 (6), 375-383, 2003 | 74 | 2003 |
What place for ethics? An overview of ethics teaching in occupational therapy and physiotherapy programs in Canada A Hudon, M Laliberté, M Hunt, V Sonier, B Williams-Jones, B Mazer, ... Disability & Rehabilitation 36 (9), 775-780, 2014 | 72 | 2014 |
Epigenetics and the environment in bioethics C Dupras, V Ravitsky, B Williams-Jones Bioethics 28 (7), 327-334, 2014 | 71 | 2014 |
‘Be ready against cancer, now’: direct-to-consumer advertising for genetic testing B Williams-Jones New Genetics and Society 25 (1), 89-107, 2006 | 66 | 2006 |
Global bioethics–myth or reality? S Holm, B Williams-Jones BMC medical ethics 7, 1-10, 2006 | 65 | 2006 |
Misconduct and misbehavior related to authorship disagreements in collaborative science E Smith, B Williams-Jones, Z Master, V Larivière, C Sugimoto, A Paul-Hus, ... Science and Engineering Ethics 26 (4), 1967-1993, 2020 | 62 | 2020 |
Ethical Issues Raised by Private Practice Physiotherapy Are More Diverse than First Meets the Eye: Recommendations from a Literature Review A Hudon, MJ Drolet, B Williams-Jones Physiotherapy Canada 67 (2), 124-132, 2015 | 62 | 2015 |
The worlds and modalities of engagement of design participants: A qualitative case study of three medical innovations P Lehoux, M Hivon, B Williams-Jones, D Urbach Design Studies 32 (4), 313-332, 2011 | 62 | 2011 |
Anticipatory governance and moral imagination: Methodological insights from a scenario-based public deliberation study P Lehoux, FA Miller, B Williams-Jones Technological Forecasting and Social Change 151, 119800, 2020 | 59 | 2020 |
Mapping translational research in personalized therapeutics: from molecular markers to health policy V Ozdemir, B Williams-Jones, DM Cooper, T Someya, B Godard Future Medicine Ltd 8 (2), 177-185, 2007 | 50 | 2007 |
Researchers’ perceptions of ethical authorship distribution in collaborative research teams E Smith, B Williams-Jones, Z Master, V Larivière, C Sugimoto, A Paul-Hus, ... Science and Engineering Ethics 26 (4), 1995-2022, 2020 | 49 | 2020 |